Machine Medicine
Machine Medicine Technologies is a London-based company at the forefront of bioelectric medicine, driving a new era of personalized, data-driven therapeutics. Their flagship product, Kelvin, is a Software as a Medical Device (SaMD) platform used globally at Deep Brain Stimulation (DBS) sites to collect high-quality data for automated clinical assessment of Parkinson's disease. Kelvin leverages advanced computer vision and pose estimation to objectively track patient movements, providing precise metrics for symptoms like tremor and bradykinesia. The company has received FDA Breakthrough Device Designation, operates with a rigorous ISO:13485-certified quality management system, and holds ISO:27001 certification for cybersecurity. They generate seven-figure annual revenues and have secured over £6.5M in funding.
Machine Medicine
Machine Medicine Technologies is a London-based company at the forefront of bioelectric medicine, driving a new era of personalized, data-driven therapeutics. Their flagship product, Kelvin, is a Software as a Medical Device (SaMD) platform used globally at Deep Brain Stimulation (DBS) sites to collect high-quality data for automated clinical assessment of Parkinson's disease. Kelvin leverages advanced computer vision and pose estimation to objectively track patient movements, providing precise metrics for symptoms like tremor and bradykinesia. The company has received FDA Breakthrough Device Designation, operates with a rigorous ISO:13485-certified quality management system, and holds ISO:27001 certification for cybersecurity. They generate seven-figure annual revenues and have secured over £6.5M in funding.
TL;DR
Headquarters: London
Flagship product: Kelvin — video-based computer-vision platform for objective motor assessment
Clinical focus: Parkinson's disease motor assessment and DBS site use
Regulatory / standards: ISO 13485, ISO 27001, FDA Breakthrough Device Designation (stated)
Recent funding: Convertible note dated 2024-12-04
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Objective motor symptom assessment and personalization of neuromodulation/neurotherapeutics (Parkinson's disease).
Founded
2017
Industry
Medical Equipment Manufacturing
Tech Stack
Funding Track Record
Most recently disclosed financing
Investor Signal
“SOSV; Meridian Health Ventures; Cedars-Sinai Accelerator; RebelBio”